Controversies about the definition of bronchopulmonary dysplasia at 50 years

Acta Paediatrica, International Journal of Paediatrics

Volumn 106, Issue 5, 2017, Pages 692-693

  Jobe, Alan H ^a   Bancalari, Eduardo H ^b  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OXYGEN; RETINOL;

AIRWAY PRESSURE; ASSISTED VENTILATION; CHORIOAMNIONITIS; EDITORIAL; HUMAN; INTRAUTERINE GROWTH RETARDATION; LOW BIRTH WEIGHT; LUNG DYSPLASIA; LUNG INJURY; PATHOPHYSIOLOGY; PHENOTYPE; PREMATURITY; PRIORITY JOURNAL; CLASSIFICATION; EXTREMELY LOW BIRTH WEIGHT; FEMALE; MALE; NEWBORN; RISK FACTOR; SEVERITY OF ILLNESS INDEX;

BRONCHOPULMONARY DYSPLASIA; FEMALE; HUMANS; INFANT, EXTREMELY LOW BIRTH WEIGHT; INFANT, NEWBORN; INFANT, PREMATURE; MALE; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 85017026676     PISSN: 08035253     EISSN: 16512227     Source Type: Journal    
DOI: 10.1111/apa.13775     Document Type: Editorial

References (11)

1. Northway WH Jr, Rosan RC, Porter DY. Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia. N Engl J Med 1967; 276: 357–68.
2. Hines D, Modi N, Lee SK, Isayama T, Sjörs G, Gagliardi L, et al. Scoping review shows wide variation in the definitions of bronchopulmonary dysplasia in preterm infants and calls for a consensus. Acta Paediatr 2017; 106: 366–74.
3. Meyer S, Franz AR, Bay J, Gortner L. Developing a better and practical definition of bronchopulmonary dysplasia. Acta Paediatr 2017; 106: 842.
4. Meyer S, Gortner L, NeoVita ATI. Early postnatal additional high-dose oral vitamin A supplementation versus placebo for 28 days for preventing bronchopulmonary dysplasia or death in extremely low birth weight infants. Neonatology 2014; 105: 182–8.
5. McEvoy CT, Jain L, Schmidt B, Abman S, Bancalari E, Aschner JL. Bronchopulmonary dysplasia: NHLBI workshop on the primary prevention of chronic lung diseases. Ann Am Thorac Soc 2014; 11(Suppl. 3): S146–53.
6. Hjalmarson O, Sandberg K. Abnormal lung function in healthy preterm infants. Am J Respir Crit Care Med 2002; 165: 83–7.
7. Laughon M, Allred EN, Bose C, O'Shea TM, Van Marter LJ, Ehrenkranz RA, et al. Patterns of respiratory disease during the first 2 postnatal weeks in extremely premature infants. Pediatrics 2009; 123: 1124–31.
8. Shennan AT, Dunn MS, Ohlsson A, Lennox K, Hoskins EM. Abnormal pulmonary outcomes in premature infants: prediction from oxygen requirement in the neonatal period. Pediatrics 1988; 82: 527–32.
9. Isayama T, Lee SK, Yang J, Lee D, Daspal S, Dunn M, et al. Revisiting the definition of bronchopulmonary dysplasia: effect of changing panoply of respiratory support for preterm neonates. JAMA Pediatr 2017. doi:10.1001/jamapediatrics.2016.4141.
10. Poindexter BB, Feng R, Schmidt B, Aschner JL, Ballard RA, Hamvas A, et al. Comparisons and limitations of current definitions of bronchopulmonary dysplasia for the prematurity and respiratory outcomes program. Ann Am Thorac Soc 2015; 12: 1822–30.
11. Beam KS, Aliaga S, Ahlfeld SK, Cohen-Wolkowiez M, Smith PB, Laughon MM. A systematic review of randomized controlled trials for the prevention of bronchopulmonary dysplasia in infants. J Perinatol 2014; 34: 705–10.